Integral Health Asset Management’s Glaukos GKOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21M Sell
150,000
-25,000
-14% -$3.16M 0.83% 35
2026
Q1
$18.8M Sell
175,000
-150,000
-46% -$16.9M 0.9% 27
2025
Q4
$36.7M Buy
325,000
+225,000
+225% +$21.5M 1.82% 13
2025
Q3
$8.15M Buy
100,000
+50,000
+100% +$4.59M 0.55% 59
2025
Q2
$5.16M Buy
+50,000
New +$4.69M 0.47% 55
2020
Q4
Sell
-40,000
Closed -$1.98M 68
2020
Q3
$1.98M Buy
+40,000
New +$1.76M 0.61% 56

Other funds holding GKOS

Integral Health Asset Management's GKOS Position: Q2 2026 in Review

Integral Health Asset Management reduced its Glaukos (GKOS) stake by 14% in Q2 2026, selling an estimated $3.16M and leaving 150,000 shares worth $21M. The position accounts for 0.83% of the portfolio, ranked #35.

Integral Health Asset Management first reported a position in GKOS in Q3 2020 and has held it in 6 quarters since. The position peaked at $36.7M in Q4 2025. 366 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Integral Health Asset Management held 150,000 shares of Glaukos worth $21M as of Q2 2026.
  • Integral Health Asset Management sold 25,000 Glaukos shares in Q2 2026, an estimated $3.16M.
  • Glaukos made up 0.83% of Integral Health Asset Management's portfolio in Q2 2026, its #35 holding.
  • Integral Health Asset Management first reported a position in Glaukos in Q3 2020 and has held it in 6 quarters since.
  • Integral Health Asset Management's Glaukos position peaked at $36.7M in Q4 2025.
  • 366 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.